Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Youji Hong"'
Autor:
Youji Hong, Yvette Robbins, Xinping Yang, Wojciech K. Mydlarz, Anastasia Sowers, James B. Mitchell, James L. Gulley, Jeffrey Schlom, Sofia R. Gameiro, Cem Sievers, Clint T. Allen
Publikováno v:
JCI Insight, Vol 7, Iss 5 (2022)
Therapeutic IL-12 has demonstrated the ability to reduce local immune suppression in preclinical models, but clinical development has been limited by severe inflammation-related adverse events with systemic administration. Here, we show that potent i
Externí odkaz:
https://doaj.org/article/087a78f2b3ee4f39ba65e786fa395d71
Autor:
Wenda Ye, Sreenivasulu Gunti, Clint T. Allen, Youji Hong, Paul E. Clavijo, Carter Van Waes, Nicole C. Schmitt
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Inhibitor of apoptosis protein (IAP) antagonists have shown activity in preclinical models of head and neck squamous cell carcinoma (HNSCC), and work across several cancer types has demonstrated diverse immune stimulatory effects including enhancemen
Externí odkaz:
https://doaj.org/article/eb5025ec4fbc4aa0aa02084fdf22ed8a
Autor:
Lawrence S. Evans, Katherine E. Lewis, Daniel DeMonte, Janhavi G. Bhandari, Logan B. Garrett, Joseph L. Kuijper, Daniel Ardourel, Martin F. Wolfson, Susan Debrot, Sherri Mudri, Kayla Kleist, Luana L. Griffin, LuAnne Hebb, Russell J. Sanderson, NingXin Wang, Michelle Seaberg, Allison G. Chunyk, Jing Yang, Youji Hong, Zahra Maria, David J. Messenheimer, Pamela M. Holland, Stanford L. Peng, Mark W. Rixon, Stacey R. Dillon
Publikováno v:
Arthritis & Rheumatology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ceb1c0338d138b60d4b730dd88a1296e
https://doi.org/10.1002/art.42462
https://doi.org/10.1002/art.42462
Autor:
Youji Hong, Yvette Robbins, Xinping Yang, Wojciech K. Mydlarz, Anastasia Sowers, James B. Mitchell, James L. Gulley, Jeffrey Schlom, Sofia R. Gameiro, Cem Sievers, Clint T. Allen
Publikováno v:
JCI insight. 7(5)
Therapeutic IL-12 has demonstrated the ability to reduce local immune suppression in preclinical models, but clinical development has been limited by severe inflammation-related adverse events with systemic administration. Here, we show that potent i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a61bad22d02bd90acf71b70a0e6df5c
https://pubmed.ncbi.nlm.nih.gov/35260537
https://pubmed.ncbi.nlm.nih.gov/35260537
Publikováno v:
Cancer Research. 80:5830-5830
Background/Objectives: Cisplatin and other cytotoxic chemotherapy drugs may induce senescence, rather than cell death, at sublethal doses. We hypothesized that the senolytic drug ABT-263 (navitoclax) might enhance cisplatin cytotoxicity and anti-tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44ca4338303af05123f2a0218e66fd2a
https://doi.org/10.1158/1538-7445.am2020-5830
https://doi.org/10.1158/1538-7445.am2020-5830